Igor F Palacios

Associate Professor--Harvard Medical School

Work Details:

Department: Department of Medicine at the Massachusetts General Hospital

Institution: Harvard Medical School

Course: Director of Interventional Cardiology

Institution (in Local Language):

Research:

Article Title/DOI: 238.Maree AO, MSc, MD, Witzke Ch, MD. Holmvang Godtfred MD, Lewis GD, MD, Jneid H, MD, Reaordona LB, MD, Afridi N, MD, Semigran MJ, MD Dec GW, MD, Low HC, MD, Palacios IF, MD. Gadolinium enhanced MRI I patients with left ventricular apical ballooning syndrome implicates Myocarditis as an Etiology. World Journal of Cardiovascular Diseases, 2013 (In press).

Journal: World Journal of Cardiovascular Diseases

VOL: 2013

Article Title: 237.Alam M, Huang HD, Shahzad SA, Kar B, Virani SS, Rogers PA, Paniagua D, Bozkurt B, Palacios I, Kleiman NS, Jneid H. Percutaneous Coronary Intervention vs. Coronary Artery Bypass Graft Surgery for Unprotected Left Main Coronary Artery Disease in the Drug-Eluting Stents Era. Circ J. 2013 Jan 25;77(2):372-82. Epub 2012 Oct 31.

Journal: Circ J.

VOL: 2013

Article Title: 236.Roos JB, Doshi SN, Konorza T, Palacios I, Schreiber T, Borisenko OV, Henriques JP. The cost-effectiveness of a new percutaneous ventricular assist device for high-risk PCI patients: mid-stage evaluation from the European perspective. J Med Econ. 2013 Jan 9. [Epub ahead of print]

Journal: J Med Econ.

VOL: 2013

Article Title: 235.Cubeddu RJ, Palacios IF, Blankenship JC, Horvath SA, Xu K, Kovacic JC, Dangas GD, Witzenbichler B, Guagliumi G, Kornowski R, Dudek D, Stone GW, Mehran R. Outcome of Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention During On- Versus Off-hours (A Harmonizing Outcomes With RevasculariZatiON and Stents in Acute Myocardial Infarction [H

Journal: amjcard

VOL: 2013

Article Title: 234.Rothman RD, Baggish AL, O'Callaghan C, Lowry PA, Bhatt AB, Macrae CA, Yannekis G, Sanborn DM, Mela T, Yeh RW, Palacios I, Vlahakes GJ, Fifer MA. Management strategy in 249 consecutive patients with obstructive hypertrophic cardiomyopathy referred to a dedicated program. Am J Cardiol. 2012 Oct 15; 110(8):1169-74.

Journal: Am J Cardiol.

VOL: 2013

RETURN